Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Opportunities in the Most Innovative Decade in History

The following video is part of our “Motley Fool Conversations” series, in which analyst John Reeves and advisor David Meier discuss topics across the investing world.

In a recent article, technologist Vivek Wadhwa laid out a compelling case that the next decade will be the most innovative yet. Here are the building blocks he sees, and some companies that are making that reality happen.

Wadhwa sees genetics, specifically genome data, changing medicine for the better. Today, Genomic Health provides genomic-based services to help cancer patients receive individualized cancer treatments. He also sees digital manufacturing, and 3-D printing as an up-and-coming force. Companies like Stratasys and 3D Systems are leading the charge. Nanotechnology continues to advance, too, and will change the way products are designed. A-1 Systems, a nanotechnology battery maker, may be struggling commercially, but its science is making progress. Like Wadhwa, we also see the growing impact of microsensors, which is why we invested in InvenSense. We’re looking for game-changing technologies like the ones mentioned above. And we think the future is going to be really cool, too.

With the U.S. relying on the rest of the world for such a large percentage of our goods, many investors are ready for the end of the "made in China" era.  Well it’s arrived, and with the balance of manufacturing power shifting yet again, you can profit with the 3 Stocks To Own For The New Industrial Revolution. They're the biggest industry disrupters we’ve seen since the personal computer, and you can read more about them in our free analyst report

David Meier owns shares of InvenSense. John Reeves has no positions in the stocks mentioned above. The Motley Fool owns shares of 3D Systems, Genomic Health, and InvenSense and has the following options: short NOV 2012 $35.00 calls on 3D Systems. Motley Fool newsletter services recommend 3D Systems, Genomic Health, and Stratasys. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Read/Post Comments (0) | Recommend This Article (10)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2000681, ~/Articles/ArticleHandler.aspx, 10/27/2016 11:26:03 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,202.72 3.39 0.02%
S&P 500 2,136.12 -3.31 -0.15%
NASD 5,237.14 -13.13 -0.25%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

12/31/1969 7:00 PM
AONEQ.DL $0.00 Down +0.00 +0.00%
A123 Systems CAPS Rating: **
DDD $14.20 Down -0.05 -0.35%
3D Systems CAPS Rating: ****
GHDX $30.40 Up +0.49 +1.64%
Genomic Health CAPS Rating: ****
INVN $6.92 Down -0.16 -2.25%
InvenSense CAPS Rating: *****
SSYS $19.94 Up +0.02 +0.10%
Stratasys CAPS Rating: ****